Dragan Grabulovski, Araris Biotech CEO
March 17, 2025 07:30 AM EDTUpdated 09:00 AM
Startups
Deals
Pharma

Ot­suka's Tai­ho buys Swiss start­up Araris with three AD­Cs near­ing the clin­ic

Kyle LaHucik

Senior Reporter

A small Swiss drug de­vel­op­er is be­ing scooped up for its pipeline of three an­ti­body-drug con­ju­gates that of­fer a next-gen­er­a­tion ap­proach to the area of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump’s HHS de­fends Biden-era stance on 340B re­bate mod­els

FDA staff re­turn to White Oak cam­pus en masse af­ter Trump ad­min­is­tra­tion push

In­cyte's stock sinks as piv­otal skin dis­ease da­ta dis­ap­point

Post-Hoc: Kennedy's an­ti-vac­cine ac­tions should­n't sur­prise any­one

As­traZeneca taps Al­teogen in deal worth more than $1.3B to make sub­cu­ta­neous can­cer drugs

George Church spin­out de­vel­op­ing ge­nom­i­cal­ly re­cod­ed or­gan­isms cuts most em­ploy­ees

A service from the Financial Times